$1.03
0.010.98%
At close: -
$1.07
0.043.88%
After Hours: 9:24 AM EDT
CytoSorbents reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of CytoSorbents using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-07 | $-0.04 | $-0.06 | 33.3 % |
Q2 | 2024-08-13 | $-0.08 | $-0.09 | 11.1 % |
Q1 | 2024-05-09 | $-0.12 | $-0.12 | 0.00 % |
Q4 | 2024-03-14 | $-0.12 | $-0.14 | 14.3 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-07 | $9.39M | $10.18M | -7.76 % |
Q2 | 2024-08-13 | $9.90M | $9.73M | 1.70 % |
Q1 | 2024-05-09 | $9.79M | $9.78M | 0.07 % |
Q4 | 2024-03-14 | $8.70M | $9.28M | -6.25 % |
CytoSorbents (CTSO) is scheduled to report earnings on March 6, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
The Actual EPS was $-0.04, which beat the estimate of $-0.06.
The Actual Revenue was $9.4M, which missed the estimate of $10.2M.
Browse earnings estimates, EPS, and revenue on all stocks.